Costco Wholesale and Beef Products are two companies that have opted to take action rather than wait for the US government to uphold its promise to strengthen consumers’ protection from E. coli. E. coli prevention previously concentrated on one prevalent strain of the bacteria, O157:H7. The US Department of Agriculture’s proposal for how to address […]
Despite drug R&D spending falling to a three-year low of $68 billion in 2010, pharmaceutical sales grew to a record $856 billion. Drug companies are spending 22% of global sales, of which only 5% come from products new to market over the past five years, on R&D. In 2010, 21 new molecular entities were introduced, […]
Renewable energy investments continued to grow in 2010, according to the latest “Global Trends in Renewable Energy Investment” report. In 2010, $211 billion was spent on renewable energy, an increase of almost a third due to stimulus funding, new guidelines, wind farm development and small-scale rooftop solar PV installation. Asset financing grew 19% to $128 […]
Two of the eight chemicals added to the 12th “Report on Carcinogens” are used every day. The report, from the NIH’s National Toxicology Program, cited repeated exposure during manufacturing as much riskier than normal exposure. Consumers were advised not to come in contact with either formaldehyde, a known carcinogen, or styrene, a probable carcinogen. Questionable […]
A survey, with a 71% response rate, of 78 small molecule drug discovery centers located at US universities or nonprofit research organizations found that cancer and infectious disease were the most prevalent therapeutic areas, with 86% and 71% of respondents, respectively, including these areas among their projects. The top three target-class focuses were phenotypic assays […]
Biotech companies in the US, Europe and Canada raised $25.0 billion in funding last year, a 7.8% increase. However, 83% of this funding went to only 20% of the companies, and financings accounted for 45% of funding, indicating that large, mature companies benefited the most. Less venture capital funding was available up front and was […]
For 47% of the nearly 400 food and beverage processors who responded to the annual Food Processing R&D survey, the most important goal for their R&D efforts this year is new product development. Existing product improvement is most important for 17%, and for 14%, cost control is the top priority. Asked to rank concerns as […]
In April, KPMG surveyed 550 financial executives at energy companies. Among respondents, 67% believe that crude oil prices will top $111 per barrel this year. For 55% of respondents, regulatory issues will be their primary challenge this year, and for 43%, they will be the biggest factor affecting capital spending decisions. Sixty-seven percent expect capital […]
In 2010, Pharmaceutical Research and Manufacturers of America (PhRMA) members spending on R&D grew 6.5% to $49.4 billion. R&D spending by the total biopharmaceutical industry grew an estimated 2.3% to $67.4 billion. PhRMA members’ domestic R&D spending rose 5.7% to $37,371.0 million, while foreign spending increased 8.7% to $12,047.4 million. As a percentage of sales, […]
In late April, the NIH released a list of cuts to grant awards in the wake of the final fiscal year 2011 budget. The $30.9 billion allocated to the NIH for fiscal 2011 is almost 1% less than what the agency received in fiscal year 2010. All modular and nonmodular noncompeting research-grant levels from NIH […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
